Zynerba reports 3Q loss

DEVON, Pa. (AP) _ Zynerba Pharmaceuticals Inc. (ZYNE) on Tuesday reported a loss of $8.3 million in its third quarter.

On a per-share basis, the Devon, Pennsylvania-based company said it had a loss of 63 cents.

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 59 cents per share.

Zynerba shares have decreased 22 percent since the beginning of the year. The stock has decreased 11 percent in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ZYNE at https://www.zacks.com/ap/ZYNE